Sangamo Therapeutics (SGMO)
(Real Time Quote from BATS)
$0.93 USD
+0.02 (1.64%)
Updated Sep 24, 2024 03:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Sangamo Therapeutics (SGMO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.80 | $8.00 | $1.00 | 313.04% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Sangamo Therapeutics comes to $3.80. The forecasts range from a low of $1.00 to a high of $8.00. The average price target represents an increase of 313.04% from the last closing price of $0.92.
Analyst Price Targets (5 )
Broker Rating
Sangamo Therapeutics currently has an average brokerage recommendation (ABR) of 1.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.86 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, four are Strong Buy, representing 57.14% of all recommendations. A month ago, Strong Buy represented 57.14%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.86 | 1.86 | 1.86 | 1.86 | 1.86 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/6/2024 | Wells Fargo Securities | Yanan Zhu | Hold | Hold |
8/7/2024 | Truist Securities | Nicole Germino | Hold | Hold |
8/7/2024 | Not Identified | Not Identified | Hold | Hold |
7/24/2024 | H.C. Wainwright & Co. | Patrick Trucchio | Strong Buy | Strong Buy |
5/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Ritu S Baral | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.86 |
ABR (Last week) | 1.86 |
# of Recs in ABR | 7 |
Average Target Price | $3.80 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | -0.07 |
SGMO FAQs
Sangamo Therapeutics, Inc. (SGMO) currently has an average brokerage recommendation (ABR) of 1.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Sangamo Therapeutics, Inc. (SGMO) is $3.80. The current on short-term price targets is based on 4 reports.
The forecasts for Sangamo Therapeutics, Inc. (SGMO) range from a low of $1 to a high of $8. The average price target represents a increase of $313.04 from the last closing price of $.92.
The current UPSIDE for Sangamo Therapeutics, Inc. (SGMO) is 313.04%
Based on short-term price targets offered by five analysts, the average price target for Sangamo Therapeutics comes to $3.80. The forecasts range from a low of $1.00 to a high of $8.00. The average price target represents an increase of 313.04% from the last closing price of $0.92.